Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertensive African Americans

被引：0
|
作者：
Narayan, P [1 ]
Papademetriou, V [1 ]
Kokkinos, P [1 ]
机构：
[1] Dept Vet Affairs Med Ctr, Washington, DC USA
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2003年 / 16卷 / 05期
关键词：
essential hypertension; angiotensin receptor blockers; African-Americans;
D O I：
10.1016/S0895-7061(03)00520-X
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P355
引用
收藏
页码：166A / 166A
页数：1
相关论文
共 50 条
  • [41] Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus
    Kawada, Tomoyuki
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 4 - 4
  • [42] Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients
    Baer, JT
    Sauer, WH
    Berlin, JA
    Kimmel, SE
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (04): : 479 - 481
  • [43] Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
    Li, Edmond C. K.
    Heran, Balraj S.
    Wright, James M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [44] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
    Potier, Louis
    Roussel, Ronan
    Elbez, Yedid
    Marre, Michel
    Zeymer, Uwe
    Reid, Christopher M.
    Ohman, Magnus
    Eagle, Kim A.
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    HEART, 2017, 103 (17) : 1339 - 1346
  • [45] Angiotensin-converting enzyme inhibitors are comparable to angiotensin II receptor blockers in the primary prevention of myocardial infarction in hypertensive patients
    Baer, JT
    Sauer, WH
    Berlin, JA
    Kimmel, SE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 531A - 531A
  • [46] ANGIOTENSIN RECEPTOR BLOCKERS VS ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN HYPERTENSIVE PATIENTS WITH SYSTOLIC DYSFUNCTION AFTER MYOCARDIAL INFARCTION
    Joo, S.
    Lee, J-G.
    Beom, J. W.
    Choi, J-H.
    Kim, S-Y.
    Kim, K-S.
    Rha, S. W.
    Jeong, J-O.
    Chae, S. C.
    Choi, D-J.
    Park, J. S.
    Jeong, M. H.
    JOURNAL OF HYPERTENSION, 2019, 37 : E82 - E82
  • [47] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19
    Covino, Marcello
    De Matteis, Giuseppe
    Burzo, Maria Livia
    Santoro, Michele
    Fuorlo, Mariella
    Sabia, Luca
    Sandroni, Claudio
    Gasbarrini, Antonio
    Franceschi, Francesco
    Gambassi, Giovanni
    INTERNAL MEDICINE JOURNAL, 2020, 50 (12) : 1483 - 1491
  • [48] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Xiao-Long Li
    Tao Li
    Qi-Cong Du
    Li Yang
    Kun-Lun He
    World Journal of Clinical Cases, 2021, 9 (20) : 5462 - 5469
  • [49] Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Liu, Chia-Lin
    Shau, Wen-Yi
    Chang, Chia-Hsuin
    Wu, Chi-Shin
    Lai, Mei-Shu
    JOURNAL OF EPIDEMIOLOGY, 2013, 23 (05) : 344 - 350
  • [50] Anti-inflammatory action of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Mascitelli, L
    Pezzetta, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 889 - 889
12345